Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesBiologics for rheumatoid arthritis: an overview of Cochrane reviews
Cochrane Reviews, 10/09/09
Singh JA et al. – Based upon indirect comparisons, anakinra seemed less efficacious than etanercept, adalimumab and rituximab and etanercept seemed to cause fewer withdrawals due to adverse events than adalimumab, anakinra and infliximab. Significant heterogeneity in characteristics of trial populations imply that these finding must be interpreted with caution. These findings can inform physicians and patients regarding their choice of biologic for treatment of RA.
Related Articles
Proinflammatory cytokines synergistically enhance the production of chemokine ligand 20 (CCL20) from rheumatoid fibroblast-like synovial cells in vitro and serum CCL20 is reduced in vivo by biologic disease-modifying antirheumatic drugs
Journal of Rheumatology, 10/05/09
Relevance Score: 90%
Abatacept for rheumatoid arthritis
Cochrane Reviews, 10/09/09
Relevance Score: 83%
ACR70-disease activity score remission achievement from switches between all the available biological agents in rheumatoid arthritis: a systematic review of the literature
Arthritis Research & Therapy, 11/17/09
Relevance Score: 82%
Assistive technology for rheumatoid arthritis
Cochrane Reviews, 10/09/09
Relevance Score: 82%
Pattern and predictors of the initiation of biologic agents for the treatment of rheumatoid arthritis in the United States: An analysis using a large observational data bank
Clinical Therapeutics, 10/16/09
Relevance Score: 81%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Taking the stress out of managing gout
Canadian Family Physician, 12/16/09
Responses to Continuous Glucose Monitoring in Subjects with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion or Multiple Daily Injections
Diabetes Technology & Therapeutics, 12/16/09
Immunosuppression Using the Mammalian Target of Rapamycin (mTOR) Inhibitor Everolimus: Pilot Study Shows Significant Cognitive and Affective Improvement
Transplantation Proceedings, 12/16/09
Today in Ortho/Rheum...keeping you current
Receive free subspecialty "5-minute updates" via email
Taking the stress out of managing gout
Canadian Family Physician, 12/16/09
Early diagnostic procedures in primary care and hospital for children with a painful hip. A prospective study
The European Journal of General Practice, 12/16/09
Motor ability in children treated for idiopathic clubfoot. A controlled pilot study
BMC Pediatrics, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor